Evessen, Germany

Irene Wagner-Döbler



 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Irene Wagner-Döbler

Introduction:

Irene Wagner-Döbler, an inventive mind based in Evessen, Germany, has made significant strides in the field of pharmaceutical research. With a passion for combating bacterial infections, she has focused her research on biofilm formations – a major challenge in medical treatments.

Latest Patents:

Wagner-Döbler holds a patent for a groundbreaking pharmaceutical composition effective against biofilms. Her invention, which includes a compound named Carolacton, demonstrates promising medical applicability in preventing the formation of biofilms by bacteria, thus paving the way for improved treatment options.

Career Highlights:

Irene currently works with Helmholtz-Zentrum für Infektionsforschung GmbH, where she contributes to research that bridges the gap between basic science and applied health solutions. Her work not only emphasizes her innovative capabilities but also her commitment to addressing real-world medical issues through scientific advancements.

Collaborations:

Throughout her career, Irene has collaborated with notable colleagues, including Brigitte Kunze and Herbert Irschik. These partnerships have further enhanced her research contributions, demonstrating the importance of teamwork in driving scientific discoveries.

Conclusion:

In summary, Irene Wagner-Döbler stands out as a remarkable inventor in the field of pharmaceutical science. Her work against biofilm formation showcases her innovative spirit and dedication to improving healthcare solutions. As research evolves, her contributions will likely continue to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…